Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema

Ophthalmology

Volumn 111, Issue 2, 2004, Pages 231-237

  Asami, Tetsu ^a   Terasaki, Hiroko ^a   Kachi, Shu ^a   Nakamura, Makoto ^a   Yamamura, Keiko ^a   Nabeshima, Toshitaka ^a   Miyake, Yozo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ATROPINE; BETAMETHASONE SODIUM PHOSPHATE; COLLAGEN FIBER; ERYTHROMYCIN; GENTAMICIN; PLASMIN;

ADULT; AGED; ARTICLE; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; FEMALE; HUMAN; HUMAN TISSUE; INTERNAL LIMITING MEMBRANE; INTERNAL LIMITING MEMBRANE PEELING; INTRAOCULAR PRESSURE ABNORMALITY; LASER COAGULATION; LIQUEFACTION; MALE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETINA; RETINA MACULA EDEMA; RETINA SURGERY; RETINA TEAR; SCANNING ELECTRON MICROSCOPY; SUCTION; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VACUUM; VITRECTOMY; VITREOUS BODY; VITREOUS BODY DETACHMENT; VITREOUS CORTEX;

EID: 0842267257     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2003.06.001     Document Type: Article

References (37)

1. Klein R., Klein B.E., Moss S.E., Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 102:1995;7-16.
2. Schepens C.L., Avila M.P., Jalkh A.E., Trempe C.L. Role of the vitreous in cystoid macular edema. Surv Ophthalmol. 28:(suppl):1984;499-504.
3. Nasrallah F.P., Jalkh A.E., van Coppenolle F., et al. The role of the vitreous in diabetic macular edema. Ophthalmology. 95:1988;1335-1339.
4. Hikichi T., Fujio N., Akiba J., et al. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology. 104:1997;473-478.
5. Lewis H., Abrams G.W., Blumenkranz M.S., Campo R.V. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology. 99:1992;753-759.
6. Harbour J.W., Smiddy W.E., Flynn H.W. Jr, Rubsamen P.E. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol. 121:1996;405-413.
7. Tachi N., Ogino N. Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol. 122:1996;258-260.
8. Pendergast S.D., Hassan T.S., Williams G.A., et al. Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol. 130:2000;178-186.
9. Gandorfer A., Messmer E.M., Ulbig M.W., Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina. 20:2000;126-133.
10. Lewis H. The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol. 131:2001;123-125.
11. Yamamoto T., Akabane N., Takeuchi S. Vitrectomy for diabetic macular edema the role of posterior vitreous detachment and epimacular membrane . Am J Ophthalmol. 132:2001;369-377.
12. Kishi S., Shimizu K. Posterior precortical vitreous pocket. Arch Ophthalmol. 108:1990;979-982.
13. Kishi S., Hagimura N., Shimizu K. The role of the premacular liquefied pocket and premacular vitreous cortex in idiopathic macular hole development. Am J Ophthalmol. 122:1996;622-628.
14. Kishi S., Demaria C., Shimizu K. Vitreous cortex remnants at the fovea after spontaneous vitreous detachment. Int Ophthalmol. 9:1986;253-260.
15. Russell S.R., Hageman G.S. Optic disc, foveal, and extrafoveal damage due to surgical separation of the vitreous. Arch Ophthalmol. 119:2001;1653-1658.
16. Liotta L.A., Goldfarb R.H., Brundage R., et al. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 41:1981;4629-4636.
17. Verstraeten T.C., Chapman C., Hartzer M., et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 111:1993;849-854.
18. Hikichi T., Yanagiya N., Kado M., et al. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 19:1999;55-58.
19. Gandorfer A., Putz E., Welge-Lüβen U., et al. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 85:2001;6-10.
20. Margherio A.R., Margherio R.R., Hartzer M., et al. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 105:1998;1617-1620.
21. Trese M.T., Williams G.A., Hartzer M.K. A new approach to stage 3 macular holes. Ophthalmology. 107:2000;1607-1611.
22. Williams J.G., Trese M.T., Williams G.A., Hartzer M.K. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology. 108:2001;1902-1905.
23. Gandorfer A., Priglinger S., Schebitz K., et al. Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol. 133:2002;156-159.
24. Gandorfer A., Ulbig M., Kampik A. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. [letter] Eye. 16:2002;95-97.
25. Li X., Shi X., Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol. 240:2002;56-62.
26. Kadonosono K., Itoh N., Uchio E., et al. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol. 118:2000;1116-1118.
27. Sebag J. Pharmacologic vitreolysis. Retina. 18:1998;1-3.
28. Tanaka M., Qui H. Pharmacological vitrectomy. Semin Ophthalmol. 15:2000;51-61.
29. Trese M.T. Enzymatic vitreous surgery. Semin Ophthalmol. 15:2000;116-121.
30. Trese M.T. Enzymatic-assisted vitrectomy. Eye. 16:2002;365-368.
31. Sebag J. Is pharmacologic vitreolysis brewing? Retina. 22:2002;1-3.
32. Gottlieb J.L., Antoszyk A.N., Hatchell D.L., Saloupis P. The safety of intravitreal hyaluronidase a clinical and histologic study . Invest Ophthalmol Vis Sci. 31:1990;2345-2352.
33. Harooni M., McMillan T., Refojo M. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase. Retina. 18:1998;16-22.
34. O'Neill R., Shea M. The effects of bacterial collagenase in rabbit vitreous. Can J Ophthalmol. 8:1973;366-370.
35. Moorhead L.C., Redburn D.A., Kirkpatrick D.S., Kretzer F. Bacterial collagenase proposed adjunct to vitrectomy with membranectomy . Arch Ophthalmol. 98:1980;1829-1839.
36. Kohno T., Sorgente N., Ishibashi T., et al. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 28:1987;506-514.
37. Kohno T., Sorgente N., Goodnight R., Ryan S.J. Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci. 28:1987;515-521.